Skip to content
Home Partnerships Streamline Bio

AI-Driven Robotic Automation for Cell Therapy Manufacturing

Delivered in partnership with Streamline Bio

Streamline Bio robotic arm in a Made Scientific cell therapy lab
PartnershipTechnology and supply
TechnologyAI-driven robotic automation
Initial focusCAR-T therapies, early- to late-phase
SitesPrinceton, NJ and East Norriton, PA

Streamline Bio Automation at Made Scientific

Early Adopter and Design Partner Program

Made Scientific and Streamline Bio are building an integrated CDMO and automation offering for therapeutic developers. The Early Adopter Program focuses on CAR-T therapies in early- to late-phase development.

  • Why CAR-T: complex, multi-step workflows can amplify variability and operational risk
  • Where we are today: Made Scientific is Streamline Bio’s exclusive early adopter, design partner, and preferred CDMO partner
  • What’s next: co-developing and validating automated workflows in a GMP-ready environment, including new unit operations and enhanced data capture

How Streamline Bio Automation Fits into Cell Therapy Manufacturing

Initial focus: CAR-T workflows

Streamline Bio’s modular robotics are designed to integrate into existing infrastructure and support diverse equipment and protocols with minimal disruption.

  • Standardize labor-intensive steps to reduce execution variability
  • Improve traceability for deviations, investigations, and comparability
  • Enable repeatable workflows for scale-up across suites

 

What Clients Can Expect

Automation that fits existing cleanrooms

The focus is practical deployment in real operating conditions, not a lab-only demo.

CDMO execution aligned to development and scale

Made Scientific supports evaluation through GMP-ready execution, including study design, process integration planning, and tech transfer considerations. The intent is to generate evidence you can use to make scale decisions with confidence.

Data capture that supports GMP expectations

Automation is paired with structured data capture to strengthen traceability and support deviations, investigations, and change control. The objective is repeatable execution with documentation rigor that stands up to scrutiny.

Repeatability across suites and shifts

The program targets consistent execution across operators and environments, supporting comparability and continuous improvement as workflows mature.

Why Partner with Made Scientific + Streamline Bio

Streamline Bio automation, deployed with Made Scientific

  • Autonomous, modular robotics built for cell therapy manufacturing
  • Validated in a live production environment at Made Scientific’s Princeton, New Jersey facility
  • Designed to integrate with common cell therapy equipment including CliniMACS Prodigy®, G-Rex®, and LOVO®

Integrated CDMO services, automation-ready by design

  • One team for evaluation, integration planning, and tech transfer
  • Structured, GMP-aligned documentation practices
Streamline Bio robotic automation system for cell therapy manufacturing

Engagement Models Built for Speed and Control

Choose the engagement model that matches your internal capabilities and the level of hands-on collaboration you want during automation evaluation and deployment:

  • Fee-for-service executionBest for defined studies with clear deliverables and timelines.
  • Dedicated team executionBest for sustained development support, rapid iteration, and parallel workstreams.
  • Hybrid client-in-plant operationsBest for joint execution, on-site knowledge transfer, and shared process ownership.
  • Early Adopter collaborationBest for teams co-developing automation workflows and extending capability across unit operations.
Made Scientific and Streamline Bio - Early Adopter Program-2

Made Scientific and Streamline Bio Launch Exclusive Early Adopter Program to Advance AI-Driven Robotic Automation for Cell Therapy Manufacturing

In February 2026, the two companies launched an exclusive Early Adopter Program to accelerate autonomous manufacturing workflows for GMP cleanroom environments.

Press Release C-2

Made Scientific and Streamline Bio Announce Collaboration to Accelerate AI-Driven Robotic Manufacturing for Cell Therapies

In October 2025, Made Scientific and Streamline Bio announced successful initial validation of Streamline Bio’s AI-driven precision robotics in a live cell therapy production environment at Made Scientific’s Princeton facility. Learn how the collaboration is advancing toward GMP integration and early adopter programs.

RoosterBio logo

RoosterBio

MSC and extracellular vesicle platforms integrated into Made Scientific’s development and manufacturing services, from process development through commercial supply.

Read the announcement
Pluristyx logo

Pluristyx

Clinical-grade iPSC lines and derivative cell types paired with Made Scientific’s process development and manufacturing expertise to support progression toward the clinic.

Explore the partnership
Syenex logo

Syenex

RapidCell™ vector technology powers MadeFast™, Made Scientific’s single-step CAR-T platform designed to reduce manufacturing time, cost, and complexity.

Explore the partnership
CARR Biosystems logo

CARR Biosystems

UniFuge® single-use centrifugation integrated across Made Scientific's Princeton and East Norriton facilities for scalable MSC manufacturing.

Explore the partnership
Cold storage units and a biosafety cabinet in a Made Scientific QC lab
Made Scientific - Interactive Background

See the Automation in Action

Get a closer look at the Streamline Bio robotic platform and find out whether your CAR-T therapy is a fit for the Early Adopter Program.